Pilot Observational Study of an Integrative Cure Stay Program

Inclusion criteria

• Breast and gynecological cancer (including but not limited to ovarian, endometrial, cervical, vulvar and vaginal cancer) survivors, including recurrent disease • Completed primary treatment (operation +/- radiation +/- chemotherapy) • Age ≥ 18 years • Ongoing or planned maintenance treatment scheduled for \> 3 months during study period is allowed (e.g. antihormonal therapy, Anti-Her2-antibodies, CDK4/6-inhibitors, Anti-VEGF-inhibitor, PARP-inhibitor, immune-checkpoint inhibitors etc.) • Signed informed consent for participation of the trials • Presence of a stoma is allowed • Prior cancer is allowed • Prior treatment - including chemotherapy - for a prior malignant tumor (including breast or gynecological cancer) is allowed • Concomitant participation in an experimental therapeutic drug trial is allowed • Use of other complementary methods (including mistletoe) is allowed • Pregnancy is allowed.